Vildagliptin as add-on to insulin improves glycaemic control without increased risk of hypoglycaemia in Asian (predominantly Chinese) patients with type 2 diabetes mellitus

被引：0
|
作者：
Ning, G. [1 ]
Wang, W. [1 ,5 ]
Li, L. [2 ]
Ma, J. [3 ]
Lv, X. [4 ]
Yang, M. [5 ]
Wang, W. [1 ,5 ]
Woloschak, M. [6 ]
Lukashevich, V. [6 ]
Kothny, W. [7 ]
机构：
[1] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Shanghai 200030, Peoples R China
[2] China Med Univ, Shengjing Hosp, Shenyang, Peoples R China
[3] Nanjing First Hosp, Nanjing, Jiangsu, Peoples R China
[4] Gen Hosp Beijing Mil Reg, Beijing, Peoples R China
[5] Beijing Novartis Pharma Co Ltd, Shanghai, Peoples R China
[6] Novartis Pharmaceut, E Hanover, NJ USA
[7] Novartis Pharma AG, Basel, Switzerland
来源：
DIABETOLOGIA | 2014年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
816
引用
收藏
页码：S330 / S330
页数：1
相关论文
共 50 条
  • [1] Vildagliptin as add-on therapy to insulin improves glycemic control without increasing risk of hypoglycemia in Asian, predominantly Chinese, patients with type 2 diabetes mellitus
    Ning, Guang
    Wang, Weiqing
    Li, Ling
    Ma, Jianhua
    Lv, Xiaofeng
    Yang, Ming
    Wang, Wei
    Woloschak, Michael
    Lukashevich, Valentina
    Kothny, Wolfgang
    [J]. JOURNAL OF DIABETES, 2016, 8 (03) : 345 - 353
  • [2] Vildagliptin as an Add-on Therapy to Insulin Improves Glycemic Control without an Increased Risk of Hypoglycemia: A Dedicated Asian Study, in a Predominantly Chinese Population
    Ning, Guan
    Wang, Weiqing
    Li, Ling
    Ma, Jianhua
    Lv, Xiaofeng
    Yang, Ming
    Wang, Wei
    Woloschak, Michael
    Lukashevich, Valentina
    Kothny, Wolfgang
    [J]. DIABETES, 2014, 63 : A274 - A274
  • [3] Improved glycaemic control without increased hypoglycaemia incidence and weight gain with insulin-vildagliptin combination therapy in Asian patients with type 2 diabetes
    Kozlovski, P.
    Foley, J.
    Shao, Q.
    Lukashevich, V.
    Kothny, W.
    [J]. DIABETOLOGIA, 2012, 55 : S355 - S355
  • [4] Improved glycaemic control with vildagliptin added to insulin, with or without metformin, in patients with type 2 diabetes mellitus
    Kothny, W.
    Foley, J.
    Kozlovski, P.
    Shao, Q.
    Gallwitz, B.
    Lukashevich, V.
    [J]. DIABETES OBESITY & METABOLISM, 2013, 15 (03): : 252 - 257
  • [5] Vildagliptin added to once or twice daily insulin regimens improves glycaemic control without increasing risk of hypoglycaemia and weight gain in patients with type 2 diabetes
    Kothny, W.
    Kozlovski, P.
    Foley, J.
    Shao, Q.
    Lukashevich, V.
    [J]. DIABETOLOGIA, 2012, 55 : S354 - S354
  • [6] Addition of vildagliptin to insulin improves glycaemic control in type 2 diabetes
    Fonseca, V.
    Schweizer, A.
    Albrecht, D.
    Baron, M. A.
    Chang, I.
    Dejager, S.
    [J]. DIABETOLOGIA, 2007, 50 (06) : 1148 - 1155
  • [7] Addition of vildagliptin to insulin improves glycaemic control in type 2 diabetes
    V. Fonseca
    A. Schweizer
    D. Albrecht
    M. A. Baron
    I. Chang
    S. Dejager
    [J]. Diabetologia, 2007, 50 : 1148 - 1155
  • [8] Efficacy and tolerability of vildagliptin as add-on therapy to metformin in Chinese patients with type 2 diabetes mellitus
    Pan, C.
    Xing, X.
    Han, P.
    Zheng, S.
    Ma, J.
    Liu, J.
    Lv, X.
    Lu, J.
    Bader, G.
    [J]. DIABETES OBESITY & METABOLISM, 2012, 14 (08): : 737 - 744
  • [9] Linagliptin improves glycemic control after 1 year as add-on therapy to basal insulin in Asian patients with type 2 diabetes mellitus
    Sheu, Wayne H. -H.
    Park, Sung Woo
    Gong, Yan
    Pinnetti, Sabine
    Bhattacharya, Sudipta
    Patel, Sanjay
    Seck, Thomas
    Woerle, Hans-Juergen
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2015, 31 (03) : 503 - 512
  • [10] Empagliflozin as add-on to basal insulin for 78 weeks improves glycaemic control with weight loss in insulin-treated type 2 diabetes mellitus
    Rosenstock, J.
    Jelaska, A.
    Wang, F.
    Kim, G.
    Broedl, U. C.
    Woerle, H. J.
    [J]. DIABETOLOGIA, 2013, 56 : S372 - S372
12345